Cocrystal (COCP): High-mutating viral diseases and small-molecule antiviral drugs Mabvax (MBVX): Cancer and human antibody-based products SciVac (SVACF): Infectious and immune diseases and recombinant biological products Sevion (SVON): Cancer and immunological diseases and antibody technology platforms
And of course the Frost marketing arm, OPK.
Does anyone have thoughts about combining vs not combining companies?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.